Novartis in plant contract dispute with Chinese CDMO Porton
A Novartis cross-border partnership is turning into a standoff. The Swiss pharma has unilaterally terminated a plant leasing…
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs Loom
With tariffs looming over biopharma, Roche became the latest industry giant to announce large-scale plans for new U.S.…